The tweet was deleted by the author.
But we saved everything 🙂.
AstraZeneca is deepening its commitment to healthcare research and development in both the U.S. and United Kingdom.
According to Warren Stephens, the pharmaceutical company is investing in transatlantic innovation, with ongoing projects in Cambridge, UK, and Cambridge, Massachusetts. Stephens recently visited The DISC in the UK, acknowledging AstraZeneca's strategy to increase support for patients and innovation on both sides of the Atlantic.
AstraZeneca has consistently prioritized research initiatives that benefit patients through cross-border collaborations, underlining the growing significance of international coordination in life sciences.
Stephens recently commented on the importance of collaboration through projects like the British-American Project, which focuses on strengthening U.S.–UK ties. He has also highlighted U.S. perspectives on economic growth opportunities in the UK after his first year as ambassador. These previous discussions frame the context for AstraZeneca’s continued cross-border initiatives.